These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Integrin-EGFR interaction regulates anoikis resistance in colon cancer cells. Guha D; Saha T; Bose S; Chakraborty S; Dhar S; Khan P; Adhikary A; Das T; Sa G Apoptosis; 2019 Dec; 24(11-12):958-971. PubMed ID: 31641961 [TBL] [Abstract][Full Text] [Related]
43. Protein tyrosine kinase 6 protects cells from anoikis by directly phosphorylating focal adhesion kinase and activating AKT. Zheng Y; Gierut J; Wang Z; Miao J; Asara JM; Tyner AL Oncogene; 2013 Sep; 32(36):4304-12. PubMed ID: 23027128 [TBL] [Abstract][Full Text] [Related]
44. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis. Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309 [TBL] [Abstract][Full Text] [Related]
45. Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression. Pessoa DO; Rius FE; Papaiz DD; Ayub ALP; Morais AS; de Souza CF; da Paixão VF; Setubal JC; Newton-Bishop J; Nsengimana J; Azevedo H; Reis EM; Jasiulionis MG Neoplasia; 2021 Apr; 23(4):439-455. PubMed ID: 33845354 [TBL] [Abstract][Full Text] [Related]
46. Anoikis resistance conferred by tenascin-C-derived peptide TNIIIA2 and its disruption by integrin inactivation. Fujita M; Sasada M; Iyoda T; Nagai R; Kudo C; Yamamoto T; Osada S; Kodama H; Fukai F Biochem Biophys Res Commun; 2021 Jan; 536():14-19. PubMed ID: 33360093 [TBL] [Abstract][Full Text] [Related]
47. beta 1 integrin regulates fibroblast viability during collagen matrix contraction through a phosphatidylinositol 3-kinase/Akt/protein kinase B signaling pathway. Tian B; Lessan K; Kahm J; Kleidon J; Henke C J Biol Chem; 2002 Jul; 277(27):24667-75. PubMed ID: 11986332 [TBL] [Abstract][Full Text] [Related]
48. pp125FAK in human melanocytes and melanoma: expression and phosphorylation. Scott G; Liang H Exp Cell Res; 1995 Jul; 219(1):197-203. PubMed ID: 7543052 [TBL] [Abstract][Full Text] [Related]
57. The AP-1 transcription factor FOSL1 causes melanocyte reprogramming and transformation. Maurus K; Hufnagel A; Geiger F; Graf S; Berking C; Heinemann A; Paschen A; Kneitz S; Stigloher C; Geissinger E; Otto C; Bosserhoff A; Schartl M; Meierjohann S Oncogene; 2017 Sep; 36(36):5110-5121. PubMed ID: 28481878 [TBL] [Abstract][Full Text] [Related]
58. The tissue inhibitor of metalloproteinases 1 increases the clonogenic efficiency of human hematopoietic progenitor cells through CD63/PI3K/Akt signaling. Rossi L; Forte D; Migliardi G; Salvestrini V; Buzzi M; Ricciardi MR; Licchetta R; Tafuri A; Bicciato S; Cavo M; Catani L; Lemoli RM; Curti A Exp Hematol; 2015 Nov; 43(11):974-985.e1. PubMed ID: 26213230 [TBL] [Abstract][Full Text] [Related]
59. TC21 mediates transformation and cell survival via activation of phosphatidylinositol 3-kinase/Akt and NF-kappaB signaling pathway. Rong R; He Q; Liu Y; Sheikh MS; Huang Y Oncogene; 2002 Feb; 21(7):1062-70. PubMed ID: 11850823 [TBL] [Abstract][Full Text] [Related]
60. Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis. Gary DS; Mattson MP J Neurochem; 2001 Mar; 76(5):1485-96. PubMed ID: 11238733 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]